Category: Psychedelics
-
![Filament Health (FN.NEO) – Five Easy Questions with Maddy]()
Filament Health (FN.NEO) – Five Easy Questions with Maddy
Welcome to Five Easy Questions with Maddy Grace where we explain the public markets and the companies that trade on them. In today’s episode, Maddy speaks with Ben Lightburn, CEO of Filament Health, a new psychedelics company with a patented process for extracting compounds naturally and bottling them in consistent dose levels. Enjoy!
-
Psychedelic Weekly Roundup with MNMD.Q, MSET.C, MYND.C, MEDI.NE, AWKN.NE, SILO, MCUR.C, NOVA.C, TRYP.C, TPIA, NEON.C
Another busy week in the psychedelic sector, with many smaller companies not always covered here at Equity Guru making news. Let’s start with the biggest players though. Mind Medicine (MNMD.Q, MMED.NE) MindMed announced that they have agreed to partner with Forian (FORA.Q), who provide evidence-based support for clinical and commercial decision making. Forian and MindMed will collaborate to…
-
![Psyched for this weeks news from CYBN.NE, PSYC.C, MNMD.Q, MSET.C, FTRP.Q, MYCO.NE, RVV.C, FH.NE, CMND.C, ATAI.Q]()
Psyched for this weeks news from CYBN.NE, PSYC.C, MNMD.Q, MSET.C, FTRP.Q, MYCO.NE, RVV.C, FH.NE, CMND.C, ATAI.Q
This week, news from the psychedelic sector has been dominated by patent applications and earnings being released. Here’s the run down of this week’s news. Cybin (CYBN.NE) It’s been a busy week for Cybin. Last week, after market close, they released their financials for the quarter ending on June 30, 2021, which showed they had…
-
![Filament Health (FH.NE) releases financials for Q2 of 2021, Tom Kineshanko transitioning from President to Founding Advisor]()
Filament Health (FH.NE) releases financials for Q2 of 2021, Tom Kineshanko transitioning from President to Founding Advisor
Filament Health (FH.NE) to release their unaudited financial results for the second quarter of 2021, a period that ended June 30, 2021. As of June 30, Filament had $7.8 million in cash and cash equivalents. This includes $5 million which was raised through a private placement that closed on June 21. That private placement included…
-
Filament Health (FH.NE) takes a natural approach to the $16 billion USD anxiety & depression market
Filament Health (FH.NE) is developing a pipeline of natural psychedelics products to treat mental health problems like depression and anxiety. August 3, 2021, FH received a patent for the technology used to transform psychedelic raw materials, like psilocybin-bearing mushroom, into pharma-grade extracts. “This approval represents important progress in the development of our IP,” stated Benjamin…
-
![Filament Health (FH.NEO) Leading the way in Natural Psychedelics. But Is it a Good Long Term Investment?]()
Filament Health (FH.NEO) Leading the way in Natural Psychedelics. But Is it a Good Long Term Investment?
In this episode, we take a look at a company that’s on a mission to get safe, natural psychedelics into the hands of everyone who needs them, as soon as possible. Filament Health (FH.NEO) is an exclusively natural psychedelic drug development company and received the first-ever psilocybin extraction and standardization patent for a public company…
-
![Filament Health (FH.NE): the natural psychedelic company flying under the radar]()
Filament Health (FH.NE): the natural psychedelic company flying under the radar
For the vast majority of the history of human use of psychedelics, they have been seen as something sacred, a gift from God or mother nature herself. Ayahuasca, which contains DMT, was given out by shamans in the Amazon as a tea. It was a spiritual experience that would purge you of your negative energy…
-
![Cybin (CYBN.N) finishes its first trading day on the NYSE]()
Cybin (CYBN.N) finishes its first trading day on the NYSE
The NYSE Cybin (CYBN.N) just finished its first trading day on the New York Stock Exchange (NYSE) after announcing the upcoming uplisting last month. It was a less than desirable day for the stock, but it’s really only a blip when factoring in the runup to the NYSE debut. In recent months we have seen…
-
![Cybin (CYBN.NE) Closes Overnight Public Offering, Fortifies Cash Balance]()
Cybin (CYBN.NE) Closes Overnight Public Offering, Fortifies Cash Balance
Cybin (CYBN.NE) announced today that it has closed its previously announced overnight marketed offering including the exercise in full of the over-allotment option granted to the Underwriters. “Investor demand for this financing was very strong and we are thankful for the outstanding work of our banking syndicate partners and advisors and we welcome all new…
-
![Filament Health (FH.NE) is experimenting with mushrooms and compounds far beyond just psilocybin]()
Filament Health (FH.NE) is experimenting with mushrooms and compounds far beyond just psilocybin
Mushroom enthusiasts Filament Health (FH.NE) is looking at mushroom compounds far beyond just psilocybin as the company is run by actual mushroom enthusiasts with access to a lot of tools. Filament has the capabilities to experiment and come up with interesting new compounds, extraction methods, and potential future products that probably go far beyond whatever…
